Company Filing History:
Years Active: 2018-2019
Title: Chandra Patel: Innovator in Factor VIII Polypeptides
Introduction
Chandra Patel is a notable inventor based in Foster City, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of variant Factor VIII polypeptides. With a total of 2 patents to her name, her work has the potential to impact therapeutic approaches for hemophilia and related disorders.
Latest Patents
Chandra Patel's latest patents focus on variant Factor VIII polypeptides and methods of their production and use. This disclosure relates to polypeptides that include amino acid substitutions at one or more positions within the thrombin cleavage site and the activation loop. In certain embodiments, the polypeptide comprises substitutions within both the thrombin cleavage site and the activation loop. Furthermore, the variant Factor VIII polypeptide may also include substitutions within the A1-A2 domain interface and the A2-A3 domain interface. The present disclosure also encompasses methods for producing and utilizing these polypeptides, as well as nucleic acids encoding them, vectors, recombinant cells, tissues, or organisms containing such nucleic acids, and kits and pharmaceutical compositions that include these polypeptides and/or nucleic acids.
Career Highlights
Chandra Patel is currently employed at Bayer Healthcare LLC, where she continues to advance her research and development efforts. Her innovative work in the field of biotechnology has positioned her as a key player in the industry.
Collaborations
Chandra has collaborated with esteemed colleagues such as Uwe Gritzan and Peter Kretschmer, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Chandra Patel's contributions to the field of biotechnology, particularly through her patents on variant Factor VIII polypeptides, highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for future therapeutic applications.